Cargando…

Patients’ rationale for declining participation in a cancer-associated weight loss study

BACKGROUND: Fewer than 5 % of cancer patients participate in clinical research. Although this paltry rate has led to extensive research on this topic, previous studies have not sought verbatim comments in a real-time, comprehensive manner to understand why patients decline. METHODS: This study used...

Descripción completa

Detalles Bibliográficos
Autores principales: Wanger, Tammy, Foster, Nathan R., Nguyen, Phuong L., Jatoi, Aminah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053567/
https://www.ncbi.nlm.nih.gov/pubmed/24622952
http://dx.doi.org/10.1007/s13539-014-0128-z
_version_ 1782320393627893760
author Wanger, Tammy
Foster, Nathan R.
Nguyen, Phuong L.
Jatoi, Aminah
author_facet Wanger, Tammy
Foster, Nathan R.
Nguyen, Phuong L.
Jatoi, Aminah
author_sort Wanger, Tammy
collection PubMed
description BACKGROUND: Fewer than 5 % of cancer patients participate in clinical research. Although this paltry rate has led to extensive research on this topic, previous studies have not sought verbatim comments in a real-time, comprehensive manner to understand why patients decline. METHODS: This study used a low-risk, non-interventional parent study that focused on cancer-associated weight loss to understand patients’ reasons for declining research participation. A research assistant wrote down the name and verbatim reason of all patients who declined to participate. These comments with accompanying patient demographic data are the subject of this report. RESULTS: Of the 334 patients, 51 (15 %) declined parent study enrollment; three comment-related themes emerged: (1) a repelling sense of too much institutional research, (2) overwhelming personal health issues, and (3) a low likelihood of returning to the institution. In univariate and multivariate analyses, only age (older) and gender (female) were associated with non-enrollment. Interestingly, 41 patients with fatigue scores of 7 or worse and 26 with pain scores of 7 or worse were enrolled. CONCLUSIONS: Although many factors were associated with declining to participate in research, symptom severity was not. Upfront education might help cancer patients better prioritize their participation in research, particularly as some patients felt overwhelmed by too much research in the institution; and for now, investigators should continue to keep asking patients for their participation.
format Online
Article
Text
id pubmed-4053567
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-40535672014-06-12 Patients’ rationale for declining participation in a cancer-associated weight loss study Wanger, Tammy Foster, Nathan R. Nguyen, Phuong L. Jatoi, Aminah J Cachexia Sarcopenia Muscle Original Article BACKGROUND: Fewer than 5 % of cancer patients participate in clinical research. Although this paltry rate has led to extensive research on this topic, previous studies have not sought verbatim comments in a real-time, comprehensive manner to understand why patients decline. METHODS: This study used a low-risk, non-interventional parent study that focused on cancer-associated weight loss to understand patients’ reasons for declining research participation. A research assistant wrote down the name and verbatim reason of all patients who declined to participate. These comments with accompanying patient demographic data are the subject of this report. RESULTS: Of the 334 patients, 51 (15 %) declined parent study enrollment; three comment-related themes emerged: (1) a repelling sense of too much institutional research, (2) overwhelming personal health issues, and (3) a low likelihood of returning to the institution. In univariate and multivariate analyses, only age (older) and gender (female) were associated with non-enrollment. Interestingly, 41 patients with fatigue scores of 7 or worse and 26 with pain scores of 7 or worse were enrolled. CONCLUSIONS: Although many factors were associated with declining to participate in research, symptom severity was not. Upfront education might help cancer patients better prioritize their participation in research, particularly as some patients felt overwhelmed by too much research in the institution; and for now, investigators should continue to keep asking patients for their participation. Springer Berlin Heidelberg 2014-03-13 2014-06 /pmc/articles/PMC4053567/ /pubmed/24622952 http://dx.doi.org/10.1007/s13539-014-0128-z Text en © Springer-Verlag Berlin Heidelberg 2014
spellingShingle Original Article
Wanger, Tammy
Foster, Nathan R.
Nguyen, Phuong L.
Jatoi, Aminah
Patients’ rationale for declining participation in a cancer-associated weight loss study
title Patients’ rationale for declining participation in a cancer-associated weight loss study
title_full Patients’ rationale for declining participation in a cancer-associated weight loss study
title_fullStr Patients’ rationale for declining participation in a cancer-associated weight loss study
title_full_unstemmed Patients’ rationale for declining participation in a cancer-associated weight loss study
title_short Patients’ rationale for declining participation in a cancer-associated weight loss study
title_sort patients’ rationale for declining participation in a cancer-associated weight loss study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053567/
https://www.ncbi.nlm.nih.gov/pubmed/24622952
http://dx.doi.org/10.1007/s13539-014-0128-z
work_keys_str_mv AT wangertammy patientsrationalefordecliningparticipationinacancerassociatedweightlossstudy
AT fosternathanr patientsrationalefordecliningparticipationinacancerassociatedweightlossstudy
AT nguyenphuongl patientsrationalefordecliningparticipationinacancerassociatedweightlossstudy
AT jatoiaminah patientsrationalefordecliningparticipationinacancerassociatedweightlossstudy